PROXY STATEMENT

Company

ABVC BIOPHARMA, INC.

Filed

December 29, 2023

Period of Report

January 16, 2024

Accession Number

0001213900-23-100009

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →